FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2031848422> ?p ?o ?g. }

• W2031848422 endingPage "1264" @default.
• W2031848422 startingPage "1253" @default.
• W2031848422 abstract "Previous studies evaluating the ability of novel oral anticoagulants (NOAC) to prevent thromboembolism in patients with non-valvular atrial fibrillation (AF) have identified differences between the efficacy and safety of the drugs tested. Whether these differences reflect differences in direct thrombin or Xa inhibition, different dosing regimens or specific aspects of each agent or trial has not yet been explored.A search was performed on MEDLINE, EMBASE and COCHRANE, and ongoing studies were tracked on clinicaltrials.gov. Phase III randomized controlled trials of direct thrombin inhibitors (DTI) and factor Xa inhibitors (FXaI) vs. warfarin in patients with AF were eligible. Data were pooled using random-effects, according to the Mantel-Haenszel model. Sensitivity analyses were performed on DTI, FXaI, once-daily and twice-daily regimens.Seven studies were pooled, including a total of 80,290 patients. Both DTI and FXaI outperformed warfarin regarding stroke or systemic embolism, intracranial bleeding, total and cardiovascular mortality. No significant differences were found between DTI and FXaI or between once-daily and twice-daily regimens. Some drugs performed worse than warfarin regarding some secondary endpoints, including: edoxaban 30 mg bid on ischaemic stroke, dabigatran on acute myocardial infarction, dabigatran 150 mg bid and rivaroxaban 20mgod on gastrointestinal bleeding.Our pooled data do not support the hypothesis of a significant class-effect of DTI or FXaI, nor the benefit of once-daily vs. twice-daily dosing in the setting of AF, reinforcing that the choice of NOAC should be adapted to the specific patient and focused on the agent itself, rather than the pharmacological class or dosing regimen." @default.
• W2031848422 created "2016-06-24" @default.
• W2031848422 creator A5013553039 @default.
• W2031848422 creator A5019792348 @default.
• W2031848422 creator A5033831989 @default.
• W2031848422 creator A5044800174 @default.
• W2031848422 creator A5066677070 @default.
• W2031848422 creator A5074774006 @default.
• W2031848422 date "2014-12-01" @default.
• W2031848422 modified "2023-09-25" @default.
• W2031848422 title "A meta-analysis of phase III randomized controlled trials with novel oral anticoagulants in atrial fibrillation: Comparisons between direct thrombin inhibitors vs. factor Xa inhibitors and different dosing regimens" @default.
• W2031848422 cites W1660053632 @default.
• W2031848422 cites W1738640266 @default.
• W2031848422 cites W1804375307 @default.
• W2031848422 cites W1978850334 @default.
• W2031848422 cites W2005501262 @default.
• W2031848422 cites W2005947177 @default.
• W2031848422 cites W2014924181 @default.
• W2031848422 cites W2023143117 @default.
• W2031848422 cites W2033102959 @default.
• W2031848422 cites W2040452288 @default.
• W2031848422 cites W2046584245 @default.
• W2031848422 cites W2083426277 @default.
• W2031848422 cites W2084430291 @default.
• W2031848422 cites W2095151586 @default.
• W2031848422 cites W2096246254 @default.
• W2031848422 cites W2097854437 @default.
• W2031848422 cites W2136489990 @default.
• W2031848422 cites W2137914777 @default.
• W2031848422 cites W2138188443 @default.
• W2031848422 cites W2144939065 @default.
• W2031848422 cites W2151074096 @default.
• W2031848422 cites W2152623033 @default.
• W2031848422 cites W2161283927 @default.
• W2031848422 cites W2162508946 @default.
• W2031848422 cites W2320128544 @default.
• W2031848422 cites W2403443153 @default.
• W2031848422 cites W4245802436 @default.
• W2031848422 cites W4255806967 @default.
• W2031848422 doi "https://doi.org/10.1016/j.thromres.2014.10.002" @default.
• W2031848422 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25457584" @default.
• W2031848422 hasPublicationYear "2014" @default.
• W2031848422 type Work @default.
• W2031848422 sameAs 2031848422 @default.
• W2031848422 citedByCount "42" @default.
• W2031848422 countsByYear W20318484222015 @default.
• W2031848422 countsByYear W20318484222016 @default.
• W2031848422 countsByYear W20318484222017 @default.
• W2031848422 countsByYear W20318484222018 @default.
• W2031848422 countsByYear W20318484222019 @default.
• W2031848422 countsByYear W20318484222020 @default.
• W2031848422 countsByYear W20318484222021 @default.
• W2031848422 countsByYear W20318484222022 @default.
• W2031848422 crossrefType "journal-article" @default.
• W2031848422 hasAuthorship W2031848422A5013553039 @default.
• W2031848422 hasAuthorship W2031848422A5019792348 @default.
• W2031848422 hasAuthorship W2031848422A5033831989 @default.
• W2031848422 hasAuthorship W2031848422A5044800174 @default.
• W2031848422 hasAuthorship W2031848422A5066677070 @default.
• W2031848422 hasAuthorship W2031848422A5074774006 @default.
• W2031848422 hasConcept C126322002 @default.
• W2031848422 hasConcept C127413603 @default.
• W2031848422 hasConcept C168563851 @default.
• W2031848422 hasConcept C2776301958 @default.
• W2031848422 hasConcept C2776710957 @default.
• W2031848422 hasConcept C2777288759 @default.
• W2031848422 hasConcept C2777292125 @default.
• W2031848422 hasConcept C2778661090 @default.
• W2031848422 hasConcept C2778810321 @default.
• W2031848422 hasConcept C2779161974 @default.
• W2031848422 hasConcept C2780290652 @default.
• W2031848422 hasConcept C2780638905 @default.
• W2031848422 hasConcept C2780645631 @default.
• W2031848422 hasConcept C42219234 @default.
• W2031848422 hasConcept C57002609 @default.
• W2031848422 hasConcept C71924100 @default.
• W2031848422 hasConcept C78519656 @default.
• W2031848422 hasConcept C89560881 @default.
• W2031848422 hasConceptScore W2031848422C126322002 @default.
• W2031848422 hasConceptScore W2031848422C127413603 @default.
• W2031848422 hasConceptScore W2031848422C168563851 @default.
• W2031848422 hasConceptScore W2031848422C2776301958 @default.
• W2031848422 hasConceptScore W2031848422C2776710957 @default.
• W2031848422 hasConceptScore W2031848422C2777288759 @default.
• W2031848422 hasConceptScore W2031848422C2777292125 @default.
• W2031848422 hasConceptScore W2031848422C2778661090 @default.
• W2031848422 hasConceptScore W2031848422C2778810321 @default.
• W2031848422 hasConceptScore W2031848422C2779161974 @default.
• W2031848422 hasConceptScore W2031848422C2780290652 @default.
• W2031848422 hasConceptScore W2031848422C2780638905 @default.
• W2031848422 hasConceptScore W2031848422C2780645631 @default.
• W2031848422 hasConceptScore W2031848422C42219234 @default.
• W2031848422 hasConceptScore W2031848422C57002609 @default.
• W2031848422 hasConceptScore W2031848422C71924100 @default.
• W2031848422 hasConceptScore W2031848422C78519656 @default.
• W2031848422 hasConceptScore W2031848422C89560881 @default.
• W2031848422 hasIssue "6" @default.
• W2031848422 hasLocation W20318484221 @default.

• next